Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Uncovering molecular mechanisms of metastatic rhabdomyosarcoma
FY 2022-23
Summary
Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma in children. Most patients with localized tumours are cured by conventional therapies; however, there are currently no available treatments that specifically target metastatic RMS and prognosis for high-risk patients remains poor. This is because we currently have insufficient understanding of the underlying biology that contributes to RMS progression, and traditionally we have lacked adequate animal models for modeling metastatic RMS and conducting pre-clinical testing of potential drug targets. Our group uses a zebrafish RMS model that highly resembles the human disease. Using our zebrafish model and available patient data, a major aim of this project will be to identify molecular differences between metastatic and non-metastatic RMS tumours, and identify critical factors that enhance RMS growth and dissemination. Furthermore, using our metastatic model, I aim to track metastasis in live zebrafish using high-resolution imaging techniques to dynamically visualize how cancer cells behave and interact with other tissues throughout tumour progression. Future preclinical investigations and drug targeting of factors unique to metastatic RMS will advance our knowledge of crucial mechanisms involved in tumour progression and inform future therapeutic strategies for high-risk RMS patients.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
486072
Name
Xiong Xueting
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Uncovering molecular mechanisms of metastatic rhabdomyosarcoma
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Fluorescent Imaging; Kras; Metastasis; Rhabdomyosarcoma; Single-Cell Rna Sequencing; Tp53; Zebrafish
Abstract
Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma in children. Most patients with localized tumours are cured by conventional therapies; however, there are currently no available treatments that specifically target metastatic RMS and prognosis for high-risk patients remains poor. This is because we currently have insufficient understanding of the underlying biology that contributes to RMS progression, and traditionally we have lacked adequate animal models for modeling metastatic RMS and conducting pre-clinical testing of potential drug targets. Our group uses a zebrafish RMS model that highly resembles the human disease. Using our zebrafish model and available patient data, a major aim of this project will be to identify molecular differences between metastatic and non-metastatic RMS tumours, and identify critical factors that enhance RMS growth and dissemination. Furthermore, using our metastatic model, I aim to track metastasis in live zebrafish using high-resolution imaging techniques to dynamically visualize how cancer cells behave and interact with other tissues throughout tumour progression. Future preclinical investigations and drug targeting of factors unique to metastatic RMS will advance our knowledge of crucial mechanisms involved in tumour progression and inform future therapeutic strategies for high-risk RMS patients.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Xiong, Xueting
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~